Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-12, with 36 holding rows worth $438,714,301.

Accession
0000945621-26-000283
Filed
2026-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 36 entries on the cover page, a total value of $438,714,301 stated on the cover page (in dollars after the unit check, H1), rows summing to $438,714,301 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM745,955$40,236,813dollars as filed
Merck & Co.,Inc.58933Y105COM363,651$38,277,904dollars as filed
Medtronic PlcG5960L103COM269,644$25,902,003dollars as filed
BECTON DICKINSON & CO075887109COM132,376$25,690,210dollars as filed
Gilead Sciences,Inc.375558103COM176,414$21,653,054dollars as filed
INCYTE CORP COM45337C102Stock218,783$21,609,197dollars as filed
Pfizer Inc.717081103COM859,539$21,402,521dollars as filed
Amgen Inc.031162100COM60,956$19,951,508dollars as filed
BIOGEN INC COM09062X103Stock85,475$15,042,745dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock184,977$14,633,530dollars as filed
CVS Health Corporation126650100COM177,599$14,094,257dollars as filed
CARDINAL HEALTH INC14149Y108COM61,946$12,729,903dollars as filed
Thermo Fisher Scientific Inc.883556102COM21,688$12,567,112dollars as filed
BRUKER CORP116794108COM254,697$11,998,776dollars as filed
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock132,478$11,912,422dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM198,505$11,797,152dollars as filed
Elevance Health, Inc.036752103COM32,546$11,409,000dollars as filed
CENTENE CORP DEL COM15135B101Stock258,109$10,621,185dollars as filed
GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK36266G107Stock114,390$9,382,268dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock96,402$8,218,271dollars as filed
AVANTOR INC COM05352A100Stock695,403$7,969,318dollars as filed
BIO RAD LABS INC090572207CL A23,750$7,196,013dollars as filed
LABCORP HOLDINGS INC COM SHS504922105Stock27,019$6,778,527dollars as filed
LANTHEUS HLDGS INC516544103COM93,823$6,243,921dollars as filed
TANDEM DIABETES CARE INC875372203COM NEW267,091$5,870,660dollars as filed
REGENERON PHARMACEUTICALS COM75886F107Stock7,165$5,530,449dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock115,000$5,353,250dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM252,062$5,295,823dollars as filed
DEXCOM INC COM252131107Stock76,122$5,052,217dollars as filed
HCA Healthcare Inc40412C101COM10,784$5,034,618dollars as filed
KURA ONCOLOGY INC COM50127T109Stock455,841$4,736,188dollars as filed
PTC THERAPEUTICS INC69366J200COM61,923$4,703,671dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR16,305$3,476,878dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK52,039$2,160,659dollars as filed
ORGANON & CO COMMON STOCK68622V106Stock300,000$2,151,000dollars as filed
CERTARA INC COM15687V109Stock230,565$2,031,278dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000945621-26-000283this filing2026-02-12acceptance time not in the bulk data set